Fact CheckerSign in

NCT02630615Active, not recruiting

Circulating Tumor Cells (CTC) in Lung Cancer

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
71 (actual)
First submitted
11 Dec 2015
Start date
19 Oct 2017
Primary completion date
31 Jul 2027
Lead sponsor
Shadia Jalal
Diseases
Lung cancer
NCT number
NCT02630615

What you commit to

  • Study type: Observational
  • Participants enrolled: 71
  • From 19 Oct 2017 to the primary completion date, 31 Jul 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Histologically or cytologically confirmed lung cancer (both non-small cell lung cancer and small cell lung cancer are allowed)
  • Stage 4 NSCLC or extensive-stage SCLC
  • Newly diagnosed disease with no prior systemic therapy for advanced disease Note: Patients that have received prior adjuvant chemotherapy or prior chemoradiotherapy for earlier stage lung cancer are allowed if treatment was completed ≥3 months.
  • Age ≥ 18 years
  • Ability to understand and the willingness to sign a written informed consent document
    • Inclusion of Women and Minorities Both men and women of all races and ethnic groups are eligible for this study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Indiana University Health Melvin and Bren Simon Cancer Center
Coordinator of this site? Confirm its status
IndianapolisUnited StatesUnknown status
Roudebush VA Medical Center
Coordinator of this site? Confirm its status
IndianapolisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.